breast cancer Archives - LifeScienceHistory.com

Roswell Park Team Identifies New Cause of Chemotherapy Resistance in Triple-Negative Breast Cancer

On Jan. 10, 2025, researchers at Roswell Park Comprehensive Cancer Center have identified a previously unknown cause of…

U.S. Surgeon General Issues New Advisory on Link Between Alcohol and Cancer Risk

On Jan. 3, 2025, the U.S. General Dr. Vivek Murthy released a new Surgeon General’s Advisory on Alcohol…

Anixa Biosciences and Cleveland Clinic Presented Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine

On Nov. 8, 2024, Anixa Biosciences announced updated positive data from the Phase 1 clinical trial of its…

Breast Cancer Mortality Continues Three Decade Decline, but Steeper Increases in Incidence for Women <50

On Oct. 1, 2024, the American Cancer Society (ACS) released Breast Cancer Statistics, 2024, the organization’s biennial update…

New cancer diagnoses did not rebound as expected following pandemic

On Sept. 24, 2024, researchers at the National Institutes of Health (NIH) reported results of a study that…

Breast and ovarian cancer linked to thousands of gene variants

On Sept. 18, 2024, researchers from the Wellcome Sanger Institute and their collaborators reported that they had identified…

False-positive mammogram results discourage some women from future screenings

On Sept. 3, 2024, a major study led by the UC Davis Comprehensive Cancer Center (UC DAVIS) has…

NCI’s Cancer Trends Progress Report announced 2023 Incidence and Mortality Data

On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…

Generation X and Millennials in U.S. Have Higher Risk of Developing 17 Cancers Compared to Older Generations

On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…

Nearly 1.8 billion adults at risk of disease from not doing enough physical activity

On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…

American Association for Cancer Research released biennial Cancer Disparities Progress Report 2024

On May 15, 2024, the American Association for Cancer Research (AACR) released its biennial Cancer Disparities Progress Report…

U.S. Preventive Services Task Force recommended all women get screened for breast cancer every other year aged 40 to 74

On Apr. 30, 2024, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…

FDA Cleared 23andMe improved BRCA report for communities underrepresented in genetic testing

On Aug. 31, 2023, the U.S. Food and Drug Administration (FDA) cleared for marketing the updated 23andMe Personal…

U.S. Preventive Services Task Force recommended that all women get screened for breast cancer every other year starting at age 40

On May 9, 2023, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…

FDA updated mammography regulations to require reporting of breast density information and facility oversight

On Mar. 9, 2023, the U.S. Food and Drug Administration (FDA) announced that it had published updates to…

WHO launched new roadmap on breast cancer

On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…

FDA approved first targeted therapy for HER2-low breast cancer

On Aug. 5, 2022, the U.S. Food and Drug Administration (FDA) approved Daiichi Sankyo’s Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV…

Anixa Biosciences Announced Publication of Peer-Reviewed Journal Article Highlighting Ovarian Cancer Vaccine Technology

On Jun. 21, 2022, Anixa Biosciences announced the publication of a peer-reviewed journal article in Clinical and Experimental…

Major study linked breast cancer treatment with increased risk of cardiovascular disease

On Apr. 6, 2022, a new study in the Journal of Clinical Oncology showed that women receiving certain…

Anixa Biosciences announced patient dosing of investigational vaccine candidate in first-of-its-kind preventative breast cancer vaccine study

On Oct. 26, 2021, Anixa Biosciences announced that, in conjunction with its partner, Cleveland Clinic, it had commenced…

Biotechnology | Disease | Genomics | Life Science News | Oncology

UTSW researchers identified new gene involved in breast cancer growth

On Jan. 12, 2021, a team researchers from the University of Texas Southwestern (UTSW) announced they had identified…

Biotechnology | Chemical | FDA | Life Science News | Therapeutics

FDA approved Merck’s KEYTRUDA (pembrolizumab) in combination with chemo for patients with TNBC

On Nov. 13, 2020, Merck announced that the U.S. Food and Drug Administration (FDA) had approved KEYTRUDA, Merck’s…

Biotechnology | FDA | Life Science News | Oncology | Therapeutics

Agilent received expanded FDA approval for PD-L1 IHC 22C3 pharmDx in triple-negative breast cancer

On Nov. 13, 2020, Agilent Technologies announced it had received U.S. Food and Drug Administration (FDA) approval for…

McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics of breast and ovarian cancer

On Nov. 4, 2020, McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics…

Seagen announced closing of $1.0 billion stock sale to Merck

On Oct. 28, 2020, Seagen announced the closing of a $1.0 billion equity investment by Merck in 5.0…

NanoString announced new GeoMx COVID-19 Consortium, part of the GeoMx Translational Leadership Network

On Sept. 9, 2020, NanoString Technologies announced the formation of the GeoMx Translational Leadership Network (GTLN). The GTLN…

University of Oxford study described which cancer patients are more vulnerable to COVID-19

On Aug. 24, 2020, a published study led by the Universities of Oxford and Birmingham found that, compared…

Pathnova Laboratories announced partnership to commercialize Todos Medicals COVID-19 and breast cancer tests in Singapore

On Aug. 3, 2020, Todos Medical announced a partnership with PATHNOVA, a Singapore-based clinical laboratory, for the Company’s…

The FDA approved new therapy for triple negative breast cancer

On Apr. 22, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy),…

breast cancer